2Jackson GH. Use of fludarabine in the treatment of acute myeloid leukemia [J]. Hematol J, 2004, 5 (suppl 1):62-67. 被引量：1
3Belhabri A, Thomas X, Wattel E, et al. All trans retinoic acid in combination with intermediate - dose cytarabine and idarubicin in patients with relapsed or refractory non promyelocytic acute myeloid leukemia: a phase Ⅱ randomized trial [ J ]. Hematol J,2002, 3 (1): 49-55. 被引量：1
4Gandhi V, Estey E, Keating M J, et al. Fludarabine potentiates metabolism of cytarabine in patients with acute myelogenous leukemia during therapy [J]. J Clin Oncol, 1993, 11 (1) : 116-124. 被引量：1
5Yamada K, Furusawa S, Saito K, et al. Concurrent use of granulocyte colony - stimulating factor with low - dose cytosine arabinoside and aclarubicin for previously treated acute myelogenous leukemia: apilot study [J]. Leukemia, 1995, 9 (1): 10-14. 被引量：1
